WallStreetZenWallStreetZen

NASDAQ: EFTR
Effector Therapeutics Inc Stock Ownership - Who owns Effector Therapeutics?

Insider buying vs selling

Have Effector Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Sr One Capital Management LLC10% Owner2023-11-27430,578$0.61
$261.36kSell
Sr One Capital Management LLC10% Owner2023-11-27178,585$0.61
$108.40kSell
Stephen T. WorlandChief Executive Officer2023-11-155,979$0.50
$2.97kBuy
Michael ByrnesChief Financial Officer2023-11-154,524$0.50
$2.25kBuy
Stephen T. WorlandChief Executive Officer2023-08-1133,799$0.52
$17.58kBuy
Michael ByrnesChief Financial Officer2023-05-154,863$0.46
$2.23kBuy
Stephen T. WorlandChief Executive Officer2023-05-156,401$0.46
$2.94kBuy

1 of 1

EFTR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EFTR insiders and whales buy or sell their stock.

EFTR Shareholders

What type of owners hold Effector Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Sr One Capital Management LLC353.51%13,035,065$175.32MInsider
Jonathan D. Root253.48%9,346,676$125.71MInsider
Brian M. Gallagher Jr.131.59%4,852,114$65.26MInsider
Abingworth LLP130.78%4,822,114$64.86MInsider
Carlyle Group Inc130.78%4,822,114$64.86MInsider
Carlyle Group Inc130.78%4,822,114$64.86MInstitution
Column Group Ii GP LP116.87%4,309,329$57.96MInsider
Presidio Management Group X LLC111.45%4,109,509$55.27MInsider
Locust Walk Sponsor LLC110.01%4,056,250$54.56MInsider
Sectoral Asset Management Inc64.62%2,382,644$32.05MInstitution

1 of 3

EFTR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EFTR18.84%81.16%Net Selling
BOLT54.74%45.26%Net Selling
MLEC0.04%9.18%
CLNN9.06%52.86%Net Buying
ELDN23.14%76.86%

Effector Therapeutics Stock Ownership FAQ

Who owns Effector Therapeutics?

Effector Therapeutics (NASDAQ: EFTR) is owned by 316.95% institutional shareholders, 1,365.58% Effector Therapeutics insiders, and 0.00% retail investors. Sr One Capital Management LLC is the largest individual Effector Therapeutics shareholder, owning 13.04M shares representing 353.51% of the company. Sr One Capital Management LLC's Effector Therapeutics shares are currently valued at $187.57M.

If you're new to stock investing, here's how to buy Effector Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.